Guangdong VTR Bio-Tech Co Ltd Asset Resilience Ratio

Latest as of March 2026: 4.98%

Guangdong VTR Bio-Tech Co Ltd asset resilience ratio. Guangdong VTR Bio-Tech Co Ltd (300381) has an Asset Resilience Ratio of 4.98% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 300381 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥143.28 Million
≈ $20.97 Million USD Cash + Short-term Investments

Total Assets

CN¥2.88 Billion
≈ $421.34 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Guangdong VTR Bio-Tech Co Ltd (2014–2025)

Asset resilience ratio of Guangdong VTR Bio-Tech Co Ltd from 2014 to 2025. This chart shows how Guangdong VTR Bio-Tech Co Ltd's Asset Resilience Ratio has changed over time. Read Guangdong VTR Bio-Tech Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Guangdong VTR Bio-Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 300381 current and non-current assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥143.28 Million 4.98%
Total Liquid Assets CN¥143.28 Million 4.98%

Asset Resilience Insights

  • Limited Liquidity: Guangdong VTR Bio-Tech Co Ltd maintains only 4.98% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Guangdong VTR Bio-Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong VTR Bio-Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Biotechnology 62.31%
Verona Pharma plc
F:I9SA
Biotechnology 0.00%
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA
Biotechnology 33.37%
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
Biotechnology 2.03%
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
Biotechnology 8.08%
Bavarian Nordic
CO:BAVA
Biotechnology 10.83%
Hebei Changshan Biochem Pharma
SHE:300255
Biotechnology -0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
Biotechnology 37.31%

Guangdong VTR Bio-Tech Co Ltd Asset Resilience Ratio by Year (2014–2025)

Guangdong VTR Bio-Tech Co Ltd asset resilience ratio by year from 2014 to 2025. The table below shows the annual Asset Resilience Ratio data for Guangdong VTR Bio-Tech Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 6.79% CN¥198.72 Million
≈ $29.08 Million
CN¥2.92 Billion
≈ $428.01 Million
-4.47pp
2024-12-31 11.26% CN¥332.13 Million
≈ $48.60 Million
CN¥2.95 Billion
≈ $431.47 Million
-6.95pp
2023-12-31 18.21% CN¥563.70 Million
≈ $82.49 Million
CN¥3.09 Billion
≈ $452.89 Million
-3.50pp
2022-12-31 21.72% CN¥688.89 Million
≈ $100.81 Million
CN¥3.17 Billion
≈ $464.18 Million
+21.56pp
2016-12-31 0.16% CN¥5.00 Million
≈ $731.66K
CN¥3.21 Billion
≈ $469.70 Million
-12.30pp
2014-12-31 12.46% CN¥120.04 Million
≈ $17.57 Million
CN¥963.36 Million
≈ $140.97 Million
--
pp = percentage points

About Guangdong VTR Bio-Tech Co Ltd

SHE:300381 China Biotechnology
Market Cap
$380.13 Million
CN¥2.60 Billion CNY
Market Cap Rank
#13388 Global
#3934 in China
Share Price
CN¥5.29
Change (1 day)
+0.00%
52-Week Range
CN¥4.99 - CN¥7.55
All Time High
CN¥34.00
About

Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services bio-enzyme preparations, biosynthetics, and nutrition and health products in China and internationally. The company offers animal nutrition and health, biofuel, detergent, food and beverage, brewing, starch sweetness, bakery, plant extracts, pulp and paper, and textile enzymes, as well as biotechnology solutions.… Read more